Guillermo O.
- Country
- Spain
- Department
- Hematology Service
Research Overview
Data & Insights
Has run more than one trial at 0 of 8 partner sites.
Specializations
Hematologic Oncology
Focused on malignant blood disorders and marrow failures, the investigator addresses aggressive and indolent forms such as acute myeloid leukemia, myelodysplastic syndrome, chronic lymphocytic leukemia, multiple myeloma, follicular lymphoma and mantle cell lymphoma.
- Acute myeloid leukemia
- Myelodysplastic syndrome
- Chronic lymphocytic leukemia
- Multiple myeloma
- Follicular lymphoma
- Mantle cell lymphoma
Therapeutic strategies include targeted agents and cellular therapies.
Solid Tumor Oncology
Broad expertise across epithelial cancers, with emphasis on molecularly defined subtypes such as breast cancer, non‑small cell lung cancer, renal cell carcinoma, colorectal cancer, gastric adenocarcinoma, head and neck squamous cell carcinoma and melanoma.
- Breast cancer
- Non‑small cell lung cancer
- Renal cell carcinoma
- Colorectal cancer
- Gastric adenocarcinoma
- Head and neck squamous cell carcinoma
- Melanoma
Investigations often target driver mutations such as KRAS, EGFR and HER2.
Autoimmune & Inflammatory Diseases
The investigator engages in immune‑mediated disorders, spanning systemic and organ‑specific conditions including systemic lupus erythematosus, rheumatoid arthritis, psoriatic arthritis, dermatomyositis, immune thrombocytopenia and other forms of vasculitis.
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Psoriatic arthritis
- Dermatomyositis
- Immune thrombocytopenia
- Vasculitis
Biologic modulation and checkpoint inhibition are explored.
Infectious Disease & Mycobacterial Infections
Research includes chronic respiratory infections and viral hepatitis, notably nontuberculous mycobacterial lung infection caused by Mycobacterium avium complex, as well as hepatitis B, hepatitis C, COVID‑19 and HIV infections.
- Nontuberculous mycobacterial lung infection
- Mycobacterium avium complex
- Hepatitis B
- Hepatitis C
- COVID‑19
- HIV
Therapeutic programs aim to improve pathogen clearance and immune response.
Cardiovascular & Metabolic Disorders
Clinical focus extends to atherosclerotic disease, cardiac dysfunction and metabolic complications, addressing atherosclerotic cardiovascular disease, heart failure, diabetes mellitus type 2, hypertriglyceridemia and associated obesity.
- Atherosclerotic cardiovascular disease
- Heart failure
- Diabetes mellitus type 2
- Hypertriglyceridemia
- Obesity
Interventions consider lipid lowering, glycemic control and anti‑inflammatory pathways.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.